1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE

This compound is a small molecule experimental drug classified as a quinazolinamine derivative. It acts as an inhibitor of inducible nitric oxide synthase (iNOS), which is involved in the production of nitric oxide during inflammatory processes. The drug has not been approved for clinical use and has no recorded indications or marketed brand names. Its molecular formula is C19H16F2N6O with an average molecular weight of approximately 382.37 g/mol. The mechanism involves inhibition of inducible nitric oxide synthase to potentially modulate inflammatory responses[1].

Other names

5-[(4′-Amino-5′,8′-difluoro-1H,1′H-spiro[piperidine-4,2′(1′H)-quinazolin]-1-yl)carbonyl]pyridine-2-carbonitrile2-Pyridinecarbonitrile, 5-[(4′-amino-5′,8′-difluorospiro[piperidine‑4,2′(1’H)-quinazolin]-1‑yl)carbonyl]253771‑21‑0